|
|
|
|
| LEADER |
01688nam a2200337 u 4500 |
| 001 |
EB001865346 |
| 003 |
EBX01000000000000001029426 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
190504 r ||| eng |
| 100 |
1 |
|
|a Pohar, Ron
|
| 245 |
0 |
0 |
|a Acceptance and commitment therapy for post-traumatic stress disorder, anxiety, and depression
|h Elektronische Ressource
|b a review of clinical effectiveness
|c Ron Pohar, Charlene Argáez
|
| 246 |
3 |
1 |
|a RC0912 ACT for PTSD, Depression, Anxiety
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2017, August 28, 2017
|
| 300 |
|
|
|a 1 PDF file (32 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Combat Disorders / therapy
|
| 653 |
|
|
|a Anxiety Disorders / therapy
|
| 653 |
|
|
|a Depressive Disorder / therapy
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Stress Disorders, Post-Traumatic / therapy
|
| 653 |
|
|
|a Acceptance and Commitment Therapy
|
| 700 |
1 |
|
|a Argáez, Charlene
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK525684
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this report is to summarize the evidence of clinical effectiveness of Acceptance and Commitment Therapy (ACT) in adult patients with trauma-related post-traumatic stress disorder, anxiety, or depression, in particular in military veterans
|